SCHEMBL4528454

SCHEMBL4528454

CN(C)S(=O)(=O)c1ccc(NC(N)=S)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.62
KMT2A Q03164 5/20 0.57
ALDH1A1 P00352 5/20 0.56
MAPT P10636 3/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 2/20 0.54
GPR55 Q9Y2T6 1/20 0.54
HSD17B10 Q99714 1/20 0.54
LMNA P02545 3/20 0.53
ABCC9 O60706 1/20 0.52
ABCC8 Q09428 1/20 0.52
KCNJ11 Q14654 1/20 0.52
KCNJ8 Q15842 1/20 0.52
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
TP53 P04637 1/20 0.51
MAPK1 P28482 1/20 0.51
TRPV4 Q9HBA0 1/20 0.51
ATM Q13315 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12903642 0.82 TSHR (0.70) SMN1; SMN2KMT2AALDH1A1MAPTMEN1
SCHEMBL11245631 0.80 TGM2 (0.54) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL7570377 0.79 GAA (0.69) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL3835013 0.78 CA2 (0.68) KMT2AALDH1A1
SCHEMBL3896906 0.78 ALDH1A1 (0.52) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL4523480 0.77 ALDH1A1 (0.52) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL11773831 0.77 CA12 (0.70) SMN1; SMN2KMT2AALDH1A1MAPTHSD17B10
SCHEMBL3896251 0.77 ALDH1A1 (0.50) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL3896252 0.77 ALDH1A1 (0.50) SMN1; SMN2KMT2AALDH1A1MAPTGAA
SCHEMBL7258699 0.76 LMNA (0.61) SMN1; SMN2KMT2AALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP disclosed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP disclosed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB SMN1; SMN2 4287/4885KMT2A 4760/4885ALDH1A1 234/4885
US-20090029998-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC SMN1; SMN2 1799/4885KMT2A 4737/4885ALDH1A1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.